TMO

679.38

1.54% -10.62

Handel nachbörslich: 675.01 -4.37 -0.64%

Thermo Fisher Scientific Inc (TMO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$690.00

Offen:

$691.31

24-Stunden-Volumen:

2.40M

Relative Volume:

1.03

Marktkapitalisierung:

$251.20B

Einnahmen:

$45.20B

Nettoeinkommen (Verlust:

$6.87B

KGV:

37.35

EPS:

18.1888

Netto-Cashflow:

$6.75B

1W Leistung:

+2.59%

1M Leistung:

+4.29%

6M Leistung:

+29.01%

1J Leistung:

+26.06%

1-Tages-Spanne:

$673.47

$692.99

1-Wochen-Bereich:

$659.00

$704.00

52-Wochen-Spanne:

$435.27

$704.00

Thermo Fisher Scientific Inc Stock (TMO) Company Profile

Firmenname

Thermo Fisher Scientific Inc

Sektor

Healthcare (1053)

Branche

Diagnostics & Research (44)

Telefon

(781) 622-1000

Adresse

168 THIRD AVENUE, WALTHAM, MA

Mitarbeiter

125,000

Twitter

@thermofisher

Nächster Verdiensttermin

2026-10-21

Neueste SEC-Einreichungen

TMO's Discussions on Twitter

Compare TMO vs DHR, NTRA, A, IDXX

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TMO Thermo Fisher Scientific Inc	679.38	251.20B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	224.43	157.77B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	399.42	57.57B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	169.90	47.90B	7.23B	1.41B	1.09B	4.979
IDXX Idexx Laboratories Inc	555.80	43.79B	4.45B	1.10B	1.06B	13.59

Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-09-09	Hochstufung	UBS	Neutral → Buy
2026-09-03	Eingeleitet	CLSA	Outperform
2026-06-26	Fortgesetzt	Bernstein	Mkt Perform
2026-06-11	Eingeleitet	Piper Sandler	Neutral
2026-06-03	Herabstufung	HSBC Securities	Buy → Hold
2026-06-02	Fortgesetzt	Wolfe Research	Outperform
2026-05-15	Fortgesetzt	RBC Capital Mkts	Sector Perform
2026-03-27	Eingeleitet	DZ Bank	Buy
2025-12-11	Hochstufung	Citigroup	Neutral → Buy
2025-12-09	Eingeleitet	Goldman	Buy
2025-12-08	Hochstufung	KeyBanc Capital Markets	Sector Weight → Overweight
2025-12-02	Fortgesetzt	Morgan Stanley	Overweight
2025-12-01	Hochstufung	HSBC Securities	Hold → Buy
2025-09-11	Hochstufung	Barclays	Equal Weight → Overweight
2025-08-19	Eingeleitet	William Blair	Outperform
2025-07-24	Herabstufung	HSBC Securities	Buy → Hold
2025-07-11	Hochstufung	Scotiabank	Sector Perform → Sector Outperform
2025-07-09	Herabstufung	UBS	Buy → Neutral
2025-01-10	Hochstufung	Bernstein	Mkt Perform → Outperform
2024-12-23	Eingeleitet	Scotiabank	Sector Perform
2024-10-14	Eingeleitet	Redburn Atlantic	Buy
2024-10-01	Eingeleitet	Stephens	Overweight
2024-08-28	Eingeleitet	Wells Fargo	Overweight
2024-06-03	Fortgesetzt	Jefferies	Buy
2024-03-18	Fortgesetzt	Citigroup	Neutral
2024-01-24	Herabstufung	Barclays	Overweight → Equal Weight
2024-01-08	Herabstufung	Bernstein	Outperform → Mkt Perform
2023-12-18	Eingeleitet	HSBC Securities	Buy
2023-12-13	Eingeleitet	Wolfe Research	Outperform
2023-10-26	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2023-10-25	Hochstufung	Wells Fargo	Underweight → Equal Weight
2023-09-28	Eingeleitet	Bernstein	Outperform
2023-09-06	Fortgesetzt	Citigroup	Buy
2023-07-19	Eingeleitet	Raymond James	Outperform
2023-07-19	Bestätigt	Robert W. Baird	Outperform
2023-07-13	Hochstufung	Credit Suisse	Neutral → Outperform
2023-04-04	Bestätigt	Barclays	Overweight
2022-12-14	Eingeleitet	Deutsche Bank	Buy
2022-12-07	Eingeleitet	RBC Capital Mkts	Outperform
2022-10-27	Herabstufung	The Benchmark Company	Buy → Hold
2022-08-25	Eingeleitet	Credit Suisse	Neutral
2022-04-25	Herabstufung	Wells Fargo	Equal Weight → Underweight
2022-01-26	Fortgesetzt	Barclays	Overweight
2021-10-20	Hochstufung	Citigroup	Neutral → Buy
2021-10-15	Fortgesetzt	Cowen	Outperform
2021-08-05	Fortgesetzt	Credit Suisse	Outperform
2021-07-16	Eingeleitet	The Benchmark Company	Buy
2021-03-18	Hochstufung	KeyBanc Capital Markets	Sector Weight → Overweight
2021-03-03	Eingeleitet	Barclays	Overweight
2021-01-08	Hochstufung	Credit Suisse	Neutral → Outperform
2020-12-16	Herabstufung	Citigroup	Buy → Neutral
2020-12-02	Eingeleitet	Goldman	Buy
2020-11-10	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2020-09-30	Eingeleitet	Atlantic Equities	Overweight
2020-09-14	Eingeleitet	Morgan Stanley	Overweight
2020-08-20	Fortgesetzt	JP Morgan	Overweight
2020-07-15	Hochstufung	Cleveland Research	Neutral → Buy
2020-07-07	Bestätigt	Needham	Buy
2020-04-23	Bestätigt	Needham	Buy
2020-01-31	Bestätigt	Needham	Buy
2020-01-22	Eingeleitet	Credit Suisse	Neutral
2020-01-08	Eingeleitet	Wells Fargo	Equal Weight
2020-01-07	Eingeleitet	Citigroup	Buy
2019-11-15	Eingeleitet	Stifel	Buy
2019-07-25	Bestätigt	Needham	Buy
2019-07-16	Herabstufung	Needham	Strong Buy → Buy
2019-05-30	Eingeleitet	Wolfe Research	Outperform
2019-05-23	Bestätigt	Needham	Strong Buy
2019-04-22	Bestätigt	Needham	Strong Buy
2019-04-16	Bestätigt	BofA/Merrill	Buy

Alle ansehen

Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten

Oct 19, 2026

Forge’s Fierce Life Sciences Announces 2026 Fierce Innovation Awards Finalists and Unveils the Fierce Vanguard Gala - GlobeNewswire Inc.

Oct 19, 2026

Beat the Market the Zacks Way: Valero Energy, Hagerty, Palantir in Focus - Zacks Investment Research

Oct 19, 2026

Clinical Trial Supplies Market Forecasts Growth from $5.7 Billion (2025) to $10.7 Billion by 2033, Profiling Thermo Fisher Scientific, Catalent, Almac Group, UPS Healthcare & 6 Other Key Players - GlobeNewswire Inc.

Oct 19, 2026

Oct 14, 2026

Global Microbiology Testing Market to Grow Rapidly at a CAGR of ~9% by 2034 | DelveInsight - GlobeNewswire Inc.

Oct 14, 2026

Thermo Fisher Scientific stock pre-market at EUR 592.70 - ad-hoc-news.de

Oct 14, 2026

Oct 13, 2026

Biotech and Pharma Rebound Strengthen Thermo’s (TMO) Organic Growth - Yahoo Finance

Oct 13, 2026

Thermo Fisher to Report Q3 Earnings: What's in the Cards? - Zacks Investment Research

Oct 13, 2026

Thermo Fisher to Report Q3 Earnings: What's in the Cards? - TradingView

Oct 13, 2026

Thermo Fisher’s Expanded Drug Lifecycle Role Might Change The Case For Investing In Thermo Fisher Scientific (TMO) - Yahoo Finance

Oct 13, 2026

TD Cowen Adjusts Price Target on Thermo Fisher Scientific to $760 From $675 - www.marketscreener.com

Oct 13, 2026

Oct 12, 2026

All You Need to Know About Thermo Fisher (TMO) Rating Upgrade to Buy - Zacks Investment Research

Oct 12, 2026

Thermo Fisher Scientific stock trades at EUR 587.70, volume is 4.1 percent of average - ad-hoc-news.de

Oct 12, 2026

Morgan Stanley Adjusts Price Target on Thermo Fisher Scientific to $730 From $650 - marketscreener.com

Oct 12, 2026

BofA raises Thermo Fisher target to USD 745 from USD 650 for Thermo Fisher Scientific stock - ad-hoc-news.de

Oct 12, 2026

Thermo Fisher Scientific stock pre-market at EUR 587.40 - ad-hoc-news.de

Oct 12, 2026

Oct 11, 2026

Thermo Fisher Stock Trades at a Premium. Can Its Earnings Keep Up? - Yahoo Finance

Oct 11, 2026

Oct 09, 2026

Thermo Fisher Scientific Inc Stock 12‑Month Price Target Raised to $682.12, Implies 5% Upside - TradingView

Oct 09, 2026

Thermo Fisher Scientific's Q3 2026 Earnings: What to Expect - Barchart.com

Oct 09, 2026

Global Decentralized Clinical Trials Market Size, Trends, and Forecast, 2025-2030 | AI, Wearables, and Cloud-Based Platforms Fuel 13.7% CAGR to $18.8 Billion - GlobeNewswire Inc.

Oct 09, 2026

Oct 08, 2026

Thermo Fisher Scientific Inc. stock falls Thursday, underperforms market - MarketWatch

Oct 08, 2026

What Could Thermo Fisher Scientific (TMO) Change With Its New Digital CMC Consortium? - Yahoo Finance

Oct 08, 2026

Why Thermo Fisher Scientific (TMO) Is Back In The Spotlight - Yahoo Finance

Oct 08, 2026

Oct 07, 2026

Thermo Fisher Scientific Inc. (1TMO.MI) stock price, news, quote and history - Yahoo Finance UK

Oct 07, 2026

Thermo Fisher Scientific Inc. (1TMO.MI) Stock Price, News, Quote & History - Yahoo! Finance Canada

Oct 07, 2026

Is This the Right Time to Add TMO Stock to Your Portfolio? - Zacks Investment Research

Oct 07, 2026

Oct 06, 2026

Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market - MarketWatch

Oct 06, 2026

JPMorgan Adds AmEx, Thermo Fisher and Liberty Energy to October Overweight Picks - BigGo Finance

Oct 06, 2026

Thermo Fisher Scientific stock heads into October 21 results after a 2.27 percent drop - AD HOC NEWS

Oct 06, 2026

Thermo Fisher Scientific (TMO): Strong Q3 Guidance and Broadening Demand Support Multi-Year Outlook - Yahoo Finance

Oct 06, 2026

Barclays Adjusts Thermo Fisher Scientific Price Target to $750 From $650, Maintains Overweight Rating - marketscreener.com

Oct 06, 2026

Quantum BioPharma Signs Contract with Thermo Fisher Scientific’s Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis - GlobeNewswire Inc.

Oct 06, 2026

Preparations begin for Quantum BioPharma's planned Phase 2 multiple sclerosis drug trial - Stock Titan

Oct 06, 2026

Exclusive: Thermo Fisher To Support Quantum Biopharma in Progressive Multiple Sclerosis Drug Trial - Benzinga

Oct 06, 2026

Thermo Fisher Scientific Showcases New Solutions and Expanded Capabilities to Accelerate Drug Development at CPHI Milan 2026 - BioSpace

Oct 06, 2026

Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation - GlobeNewswire Inc.

Oct 06, 2026

Thermo Fisher Scientific Showcases New Solutions and Expanded Capabilities to Accelerate Drug Development at CPHI Milan 2026 - Business Wire

Oct 06, 2026

Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific - Zacks Investment Research

Oct 06, 2026

Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific - TradingView

Oct 06, 2026

Oct 05, 2026